# Study on the Safety and Effectiveness of a Biodegradable Patent Foramen Ovale Occluder System

> **NCT07300358** · NA · NOT_YET_RECRUITING · sponsor: **Shanghai Lingsi Medical Technology Co., Ltd.** · enrollment: 258 (estimated)

## Conditions studied

- Cardiovascular Diseases
- Cardiovascular Abnormality
- Heart Defects, Congenital
- Heart Septal Defects
- Heart Septal Defects, Atrial
- Foramen Ovale, Patent
- Stroke, Ischemic
- Stroke (CVA) or TIA

## Interventions

- **DEVICE:** Active Comparator
- **DEVICE:** Experimental

## Key facts

- **NCT ID:** NCT07300358
- **Lead sponsor:** Shanghai Lingsi Medical Technology Co., Ltd.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-30
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 258 (ESTIMATED)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07300358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07300358, "Study on the Safety and Effectiveness of a Biodegradable Patent Foramen Ovale Occluder System". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07300358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*